Výsledky vyhledávání - "Eric, Sondag"

Phase 1 and 2 Randomized Clinical Studies Determine Lack of Efficacy for Anti-IL-17C Antibody MOR106 in Moderate–Severe Atopic Dermatitis

Autor: Diamant Thaçi, Dave Singh, Mark Lee, Helen Timmis, Dominique Jacobs, Paul Passier, Susanne Rohrer, Johan Beetens, De Phung, Eric Sondag, Goran Babic, Guido Würth, Pia Kloepfer, Stefan Härtle, Silke Hüttner

Publikováno v: Journal of Clinical Medicine; Volume 11; Issue 23; Pages: 7244

Interleukin 17C (IL-17C) modulates epithelial inflammation and has a possible role in atopic dermatitis (AD) pathology. Four randomized clinical studies (Phase 1 and 2) investigated the safety, tolerability, efficacy, and pharmacokinetic profile of t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95edd5097eb70322d3c2b0b4d234e2f9
https://doi.org/10.3390/jcm11237244

Zobrazit plný text záznamu

Plný text ve formátu HTML

Effects of betahistine on patient-reported outcomes in routine practice in patients with vestibular vertigo and appraisal of tolerability: experience in the OSVaLD study

Autor: Heike, Benecke, Herminio, Pérez-Garrigues, Dinsuhaimi, Bin Sidek, Ingrida, Uloziene, Kuessner, D, Eric, Sondag, Ad, Theeuwes, Algarra J, Marco

Publikováno v: The international tinnitus journal. 16(1)

This was a 3-month multicentre, open-label post-marketing surveillance study of betahistine (24 mg b.i.d. or 16 mg t.i.d.) in patients with vertigo of peripheral vestibular origin. Study endpoints comprised on-treatment changes in the Dizziness Handi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f05539b070effca4987cb2ea4aad0357
https://pubmed.ncbi.nlm.nih.gov/21609908

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání